# Aytu BioPharma (AYTU) — Earnings

AYTU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aytu/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.00 |
| EPS estimate | −$0.29 |
| EPS surprise | +100.00% |
| Revenue surprise | +31.20% |
| Revenue | $16.1M |
| Revenue estimate | $12.3M |
| Reported | Sep 22, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1385818/000143774926030900/aytu20260502_8k.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/4ee69b0c-ee76-33fb-7434-f6e8d1e5683b.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2026 | Sep 22, 2026 | −$0.29 | $0.00 | 100.00% | $12.3M | $16.1M |
| Q3 2026 | May 13, 2026 | −$0.44 | −$0.53 | -19.56% | $12.1M | $12.4M |
| Q2 2026 | Feb 3, 2026 | −$0.41 | −$1.05 | -158.18% | $12.2M | $15.2M |
| Q1 2026 | Nov 13, 2025 | −$0.19 | −$0.08 | 57.89% | $12.6M | $13.9M |
| Q4 2025 | Sep 23, 2025 | −$0.03 | −$2.93 | -8698.80% | $17.9M | $15.1M |
| Q3 2025 | May 14, 2025 | −$0.17 | $0.20 | 217.65% | $13.7M | $18.5M |
| Q2 2025 | Feb 12, 2025 | −$0.28 | −$0.28 | 0.00% | $15.6M | $16.2M |
| Q1 2025 | Nov 13, 2024 | −$0.34 | −$0.20 | 41.18% | $13.8M | $16.6M |
| Q4 2024 | Sep 26, 2024 | −$0.45 | −$0.82 | -82.22% | $18.3M | $18.0M |
| Q3 2024 | May 15, 2024 | −$0.64 | −$0.52 | 18.75% | $17.3M | $18.0M |
| Q2 2024 | Feb 14, 2024 | −$0.25 | −$0.04 | 84.00% | $21.7M | $22.9M |
| Q1 2024 | Nov 14, 2023 | −$0.04 | −$1.48 | -3600.00% | $27.7M | $22.1M |
| Q4 2023 | Sep 27, 2023 | −$0.95 | −$0.59 | 37.89% | $27.7M | $30.7M |
| Q3 2023 | May 11, 2023 | −$0.63 | −$1.93 | -206.35% | $28.0M | $22.7M |
| Q2 2023 | Feb 21, 2023 | −$0.70 | −$2.15 | -207.14% | $29.5M | $26.3M |
| Q1 2023 | Nov 14, 2022 | −$3.60 | −$1.20 | 66.67% | $24.3M | $27.7M |
| Q4 2022 | Sep 27, 2022 | −$4.80 | −$9.80 | -104.17% | $25.7M | $27.4M |
| Q3 2022 | May 16, 2022 | −$22.00 | −$35.80 | -62.73% | $24.2M | $24.2M |
| Q2 2022 | Feb 14, 2022 | −$8.80 | −$8.80 | 0.00% | $23.1M | $23.1M |
| Q1 2022 | Nov 15, 2021 | −$9.80 | −$21.80 | -122.45% | $22.1M | $21.9M |

## Frequently Asked Questions

### When did Aytu BioPharma (AYTU) last report earnings?

Aytu BioPharma last reported on Sep 22, 2026, covering fiscal Q4 2026.

### Did AYTU beat earnings estimates?

Yes. Aytu BioPharma reported EPS of $0.00 for Q4 2026 against a −$0.29 estimate — a 100.00% beat.

### How much revenue did AYTU report last quarter?

Aytu BioPharma reported $16.1M in revenue for Q4 2026, against a consensus estimate of $12.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).